NOV 29, 2016 8:11 AM PST

New cholesterol drugs might target this protein

Image Credit: Getty Images

Scientists have identified a protein that binds to LDL cholesterol and helps transport it. Blocking the protein might offer a new way to fight heart disease.

Arteries become clogged with fats and cholesterol when certain proteins in the body, known as lipoproteins, combine with and transport fats in the blood to cells.

Scientists have long believed that the LDL receptor molecule was responsible for the transport of LDL within cells. But given that some individuals lacking the LDL receptor still have high levels of LDL, questions remained about the mechanism.

To identify the mechanism, the research team screened more than 18,000 genes from the endothelium—the inner layer of human blood vessels. They examined the transfer of LDL into endothelial cells and then focused on possible genes involved in the process.

The researchers found that a protein called ALK1 facilitated LDL’s pathway into cells. The results appear in Nature Communications.

“We confirmed that ALK1 directly binds to LDL,” says William C. Sessa, senior author and a professor of pharmacology and medicine (cardiology) at Yale University.

The team also determined that the “LDL-ALK1 pathway” aided the transport of LDL from blood into tissue.

The role of ALK1 in LDL accumulation was not previously known, adds Sessa.

“The discovery of ALK1 as an LDL-binding protein implies that it might initiate the early phases of atherosclerosis,” he says. “If we can find a way of blocking ALK1 using small molecules or antibodies, it might be used in combination with lipid-lowering strategies.”

Current lipid-lowering strategies include statins, which target LDL cholesterol levels in the blood.

A therapeutic that blocks ALK1 “would be a unique strategy for reducing the burden of atherosclerosis and be synergistic with lipid- lowering therapies,” Sessa says.

The Yale Center for Molecular Discovery, the National Institutes of Health, and the American Heart Association supported the research.

Source: Yale University

This article was originally published on Futurity.org.
About the Author
  • Futurity features the latest discoveries by scientists at top research universities in the US, UK, Canada, Europe, Asia, and Australia. The nonprofit site, which launched in 2009, is supported solely by its university partners (listed below) in an effort to share research news directly with the public.
You May Also Like
JUL 20, 2019
Cardiology
JUL 20, 2019
Hacking Fat Cells
The high-fat energy-dense diet we consume today is nothing like what humans ate for all of history before us. Luckily, we no longer have to hunt and kill o...
SEP 18, 2019
Cardiology
SEP 18, 2019
Clear, Flexible Vital Sign Wearable Monitors
Wearable health monitors are gaining in popularity, both for fitness tracking and for gathering more targeted health data relating to heart disease and oth...
SEP 07, 2019
Cardiology
SEP 07, 2019
Your Brain On Cardiovascular Exercise
There is an increasing number of studies that explore the connection between exercise and the brain. These studies have revealed some fascinating connectio...
OCT 24, 2019
Cardiology
OCT 24, 2019
Protein Build-Up Places Heart at Risk
Amyloidosis is a disease caused by protein buildup in the body. These abnormal proteins, called amyloids, are produced in the bone marrow. Multiple types o...
JAN 03, 2020
Cardiology
JAN 03, 2020
Invasive Surgery isn't Worth it For All Heart Disease Patients
Invasive procedures are no better than medications and lifestyle advice at treating heart disease that’s severe but stable, according to new research...
JAN 03, 2020
Cardiology
JAN 03, 2020
Healthy Sleep May Offset Genetic Heart Disease Risk
People with a high genetic risk of heart disease or stroke may be able to offset that risk with healthy sleep patterns, according to new research. The rese...
Loading Comments...